- Consumer Products
- Latest 47.21
- Currency US$
- Change 0.98
- Percent Change 2.12 %
- Volume 4,055,353
- Wed Apr 16, 2014 04:00 PM EDT NASDAQ data delayed 15 minutes.
12 months ended Dec 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Feb 27||$0.75||May 1||$0.63|
12 months ended Apr 17, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
Mylan Inc. is one of the world's leading quality generic and specialty pharmaceutical companies. The Company offers one of the industry's broadest and highest quality product portfolios, a robust product pipeline and a global commercial footprint through operations in more than 90 countries. Through its controlling interest in Matrix Laboratories Limited, Mylan has direct access to one of the largest active pharmaceutical ingredient manufacturers in the world. Dey L.P., Mylan's fully integrated specialty business, provides the Company with innovative and diversified opportunities in the respiratory and allergy therapeutic areas.
Head Office1500 CORPORATE DRIVE